Suppr超能文献

一种基于植物和食品衍生天然产物共组装的智能双药纳米系统用于协同肝癌免疫治疗。

A smart dual-drug nanosystem based on co-assembly of plant and food-derived natural products for synergistic HCC immunotherapy.

作者信息

Zhang Bingchen, Jiang Jiali, Wu Pengyu, Zou Junjie, Le Jingqing, Lin Juanfang, Li Chao, Luo Bangyue, Zhang Yongjie, Huang Rui, Shao Jingwei

机构信息

Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, College of Chemistry, Fuzhou University, Fuzhou 350116, China.

Institute of Oceanography, Minjiang University, Fuzhou 350108, China.

出版信息

Acta Pharm Sin B. 2021 Jan;11(1):246-257. doi: 10.1016/j.apsb.2020.07.026. Epub 2020 Aug 19.

Abstract

Nanotechnology has emerged as an ideal approach for achieving the efficient chemo agent delivery. However, the potential toxicity and unclear internal metabolism of most nano-carriers was still a major obstacle for the clinical application. Herein, a novel "core‒shell" co-assembly carrier-free nanosystem was constructed based on natural sources of ursolic acid (UA) and polyphenol (EGCG) with the EpCAM-aptamer modification for hepatocellular carcinoma (HCC) synergistic treatment. As the nature products derived from food-plant, UA and EGCG had good anticancer activities and low toxicity. With the simple and "green" method, the nanodrugs had the advantages of good stability, pH-responsive and strong penetration of tumor tissues, which was expected to increase tumor cellular uptake, long circulation and effectively avoid the potential defects of traditional carriers. The nanocomplex exhibited the low cytotoxicity in the normal cells good biosafety of organic tissues and efficient tumor accumulation . Importantly, UA combined with EGCG showed the immunotherapy by activating the innate immunity and acquired immunity resulting in significant synergistic therapeutic effect. The research could provide new ideas for the research and development of self-assembly delivery system in the future, and offer effective intervention strategies for clinical HCC treatment.

摘要

纳米技术已成为实现高效化疗药物递送的理想方法。然而,大多数纳米载体的潜在毒性和不明的体内代谢仍是其临床应用的主要障碍。在此,基于天然来源的熊果酸(UA)和多酚(表没食子儿没食子酸酯,EGCG)构建了一种新型的“核 - 壳”共组装无载体纳米系统,并通过上皮细胞黏附分子(EpCAM)适配体修饰用于肝细胞癌(HCC)的协同治疗。作为源自食用植物的天然产物,UA和EGCG具有良好的抗癌活性和低毒性。通过简单且“绿色”的方法,纳米药物具有稳定性好、pH响应性以及对肿瘤组织的强穿透性等优点,有望增加肿瘤细胞摄取、实现长循环并有效避免传统载体的潜在缺陷。该纳米复合物在正常细胞中表现出低细胞毒性、对有机组织具有良好的生物安全性以及高效的肿瘤蓄积。重要的是,UA与EGCG联合通过激活固有免疫和获得性免疫显示出免疫治疗作用,从而产生显著的协同治疗效果。该研究可为未来自组装递送系统的研发提供新思路,并为临床肝癌治疗提供有效的干预策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/562f/7838026/028502e3a761/fx1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验